Nuvation Bio Inc. (NUVB) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $164.09M | +359.3% |
| 2024 | $35.72M | -16.2% |
| 2023 | $42.65M | -57.8% |
| 2022 | $101.10M | -23.7% |
| 2021 | $132.42M | +345.0% |
| 2020 | $29.75M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $164.09M | +359.3% |
| 2024 | $35.72M | -16.2% |
| 2023 | $42.65M | -57.8% |
| 2022 | $101.10M | -23.7% |
| 2021 | $132.42M | +345.0% |
| 2020 | $29.75M | — |